Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: April 1, 2023

STIMATE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions

When do Stimate patents expire, and when can generic versions of Stimate launch?

Stimate is a drug marketed by Ferring Pharms Inc and is included in one NDA.

The generic ingredient in STIMATE is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Stimate

A generic version of STIMATE was approved as desmopressin acetate by TEVA PHARMS USA on October 15th, 1997.

  Sign Up

Summary for STIMATE
Drug patent expirations by year for STIMATE
Drug Prices for STIMATE

See drug prices for STIMATE

Recent Clinical Trials for STIMATE

Identify potential brand extensions & 505(b)(2) entrants

Genentech, Inc.Phase 4
Indiana Hemophilia &Thrombosis Center, Inc.Phase 4
Canadian Hemophilia SocietyPhase 4

See all STIMATE clinical trials

US Patents and Regulatory Information for STIMATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms Inc STIMATE desmopressin acetate SPRAY, METERED;NASAL 020355-001 Mar 7, 1994 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ferring Pharms Inc STIMATE (NEEDS NO REFRIGERATION) desmopressin acetate SPRAY, METERED;NASAL 020355-002 Oct 24, 2007 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.